Literature DB >> 12208410

Outcome of idiopathic restrictive cardiomyopathy in children.

Rachel J Weller1, Robert Weintraub, Linda J Addonizio, Maryanne R K Chrisant, Welton M Gersony, Daphne T Hsu.   

Abstract

Eighteen children with idiopathic restrictive cardiomyopathy (IRC) were studied in an attempt to identify potential predictors of poor outcome. Four patients presented with low cardiac output (CO) syndrome. Fourteen remaining patients were minimally symptomatic at presentation but developed a low CO syndrome at a mean of 2.8 +/- 2.3 years after diagnosis. At the time of development of low CO in the 18 patients, mean left ventricular end-diastolic pressure was 27 mm Hg, right ventricular end-diastolic pressure was 18 mm Hg, cardiac index was 2.5 L/min/m(2), and pulmonary vascular resistance index (PVRI) was 8.8 U-m(2). Eleven of the 18 patients underwent cardiac transplantation. One died perioperatively from donor right-sided cardiac failure and 10 survived. Six were not transplanted and died, including 3 in whom transplantation was precluded secondary to extremely elevated PVRI. One patient is alive with right-sided cardiac failure. Ten of our 18 patients had pulmonary hypertension (PVRI >6 U-m(2)) at the time of referral for cardiac transplant and/or development of low CO syndrome. In comparison, children with dilated cardiomyopathy who were referred for heart transplant during the same time period had a PVRI that was significantly lower (5.2 U-m(2)). Elevated PVRI was associated with death (p <0.01) and 40% of our children with pulmonary hypertension were precluded from receiving an orthotopic heart transplant because their pulmonary hypertension was so severe. No risk factors for the development of pulmonary hypertension were identified; therefore, all children with IRC should undergo serial monitoring of their PVRI, and any increase should prompt a transplant evaluation.

Entities:  

Mesh:

Year:  2002        PMID: 12208410     DOI: 10.1016/s0002-9149(02)02522-5

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  16 in total

1.  Heart and heart-lung transplantation for idiopathic restrictive cardiomyopathy in children.

Authors:  M J Fenton; H Chubb; A M McMahon; P Rees; M J Elliott; M Burch
Journal:  Heart       Date:  2006-01       Impact factor: 5.994

2.  Utility of Doppler tissue imaging-derived indices in identifying subclinical systolic ventricular dysfunction in children with restrictive cardiomyopathy.

Authors:  Nao Sasaki; Mario Garcia; Irene Lytrivi; H Ko; James Nielsen; Ira Parness; Shubhika Srivastava
Journal:  Pediatr Cardiol       Date:  2011-03-27       Impact factor: 1.655

Review 3.  Pediatric Cardiomyopathies.

Authors:  Teresa M Lee; Daphne T Hsu; Paul Kantor; Jeffrey A Towbin; Stephanie M Ware; Steven D Colan; Wendy K Chung; John L Jefferies; Joseph W Rossano; Chesney D Castleberry; Linda J Addonizio; Ashwin K Lal; Jacqueline M Lamour; Erin M Miller; Philip T Thrush; Jason D Czachor; Hiedy Razoky; Ashley Hill; Steven E Lipshultz
Journal:  Circ Res       Date:  2017-09-15       Impact factor: 17.367

4.  Utility of Echocardiography in the Assessment of Left Ventricular Diastolic Function and Restrictive Physiology in Children and Young Adults with Restrictive Cardiomyopathy: A Comparative Echocardiography-Catheterization Study.

Authors:  Thomas D Ryan; Peace C Madueme; John L Jefferies; Erik C Michelfelder; Jeffrey A Towbin; Jessica G Woo; Rashmi D Sahay; Eileen C King; Roberta Brown; Ryan A Moore; Michelle A Grenier; Bryan H Goldstein
Journal:  Pediatr Cardiol       Date:  2016-11-23       Impact factor: 1.655

5.  Fetal cardiac troponin isoforms rescue the increased Ca2+ sensitivity produced by a novel double deletion in cardiac troponin T linked to restrictive cardiomyopathy: a clinical, genetic, and functional approach.

Authors:  Jose Renato Pinto; Shi Wei Yang; Marc-Phillip Hitz; Michelle S Parvatiyar; Michelle A Jones; Jingsheng Liang; Victor Kokta; Mario Talajic; Nicolas Tremblay; Michelle Jaeggi; Gregor Andelfinger; James D Potter
Journal:  J Biol Chem       Date:  2011-04-18       Impact factor: 5.157

6.  Idiopathic restrictive cardiomyopathy in children.

Authors:  L M Russo; S A Webber
Journal:  Heart       Date:  2005-09       Impact factor: 5.994

7.  Dose-dependent diastolic dysfunction and early death in a mouse model with cardiac troponin mutations.

Authors:  Yuejin Li; Lei Zhang; Pierre-Yves Jean-Charles; Changlong Nan; Guozhen Chen; Jie Tian; J-P Jin; Ira J Gelb; Xupei Huang
Journal:  J Mol Cell Cardiol       Date:  2013-06-26       Impact factor: 5.000

8.  Insights into restrictive cardiomyopathy from clinical and animal studies.

Authors:  Pierre-Yves Jean-Charles; Yue-Jin Li; Chang-Long Nan; Xu-Pei Huang
Journal:  J Geriatr Cardiol       Date:  2011-09       Impact factor: 3.327

Review 9.  Patient and Device Selection in Pediatric MCS: A Review of Current Consensus and Unsettled Questions.

Authors:  Joshua M Friedland-Little; Anna Joong; Svetlana B Shugh; Matthew J O'Connor; Neha Bansal; Ryan R Davies; Michelle S Ploutz
Journal:  Pediatr Cardiol       Date:  2022-03-24       Impact factor: 1.838

10.  Novel Phenotype-Genotype Correlations of Restrictive Cardiomyopathy With Myosin-Binding Protein C (MYBPC3) Gene Mutations Tested by Next-Generation Sequencing.

Authors:  Wei Wu; Chao-Xia Lu; Yi-Ning Wang; Fang Liu; Wei Chen; Yong-Tai Liu; Ye-Chen Han; Jian Cao; Shu-Yang Zhang; Xue Zhang
Journal:  J Am Heart Assoc       Date:  2015-07-10       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.